{"id":28842,"date":"2016-11-18T19:00:38","date_gmt":"2016-11-18T18:00:38","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=28842"},"modified":"2016-11-18T19:00:38","modified_gmt":"2016-11-18T18:00:38","slug":"dompe-acquisisce-il-ramo-dazienda-farma-dal-gruppo-bracco","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/dompe-acquisisce-il-ramo-dazienda-farma-dal-gruppo-bracco\/","title":{"rendered":"Domp\u00e9 acquires the Farma business branch from the Bracco group"},"content":{"rendered":"<p><img decoding=\"async\" class=\"alignleft\" src=\"http:\/\/www.italiaoggi.it\/upload\/img\/ITALIAOGGI\/201611181153258290\/dompe-bracco-609792.jpg\" alt=\"Domp\u00e9 acquisisce il ramo d'azienda Farma dal gruppo Bracco\" \/>Bracco and Domp\u00e9 have signed an agreement through which the Pharma division of the Bracco group will become part of the Italian biopharmaceutical group led by Sergio Domp\u00e9.<\/p>\n<p>The closing is expected by the end of the year. The value of the transaction was not disclosed.<\/p>\n<p>The pharmaceutical division of Bracco, for which a turnover of around 80 million euro is expected in 2016 (equal to 6% of the group&#039;s turnover), operates exclusively on the Italian market with a product portfolio that includes both ethical drugs belonging to the main therapeutic sectors such as the gastrointestinal, neurological, endocrinological and cardiovascular ones, as well as over-the-counter drugs and supplements, with some well-known brands.<\/p>\n<p><a href=\"http:\/\/www.italiaoggi.it\/news\/dettaglio_news.asp?id=201611181153258290&amp;chkAgenzie=ITALIAOGGI&amp;titolo=Domp%C3%A9%20acquisisce%20il%20ramo%20d%27azienda%20Farma%20dal%20gruppo%20Bracco\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">18 November 2016 \u2013 Italy Today<\/span><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Bracco e Domp\u00e9 hanno siglato un accordo attraverso il quale la divisione Farma del gruppo Bracco entrer\u00e0 a far parte del gruppo biofarmaceutico italiano guidato da Sergio Domp\u00e9. Il closing \u00e8 previsto entro la fine dell`anno. Il valore dell&#8217;operazione non \u00e8 stato comunicato. La divisione farmaceutica di Bracco, per la quale nel 2016 \u00e8 atteso &hellip;<\/p>","protected":false},"author":4,"featured_media":19314,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[53],"class_list":["post-28842","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-fusioniacquisizioni"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/28842","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=28842"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/28842\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/19314"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=28842"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=28842"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=28842"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}